Freehand CEO：药品供应链扰动近乎每季发生，药企转向可感知与转向的运营模式
Pharma Rethinks Supply Chain Planning as Disruptions Mount
Freehand联合创始人兼CEO Nitin Jayakrishnan在LogiPharma USA 2026上表示，制药供应链过去视为罕见事件的扰动如今几乎每季度都在发生，这一节奏可追溯至新冠疫情及其后的全球关税战、武装冲突、AI驱动的波动和影响全球团队企业的移民政策。他称药企正以旨在感知与转向的运营模式取代长期计划。
News|Videos|October 7, 2026
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
According to Nitin Jayakrishnan, co-founder and CEO of Freehand, disruptions that pharmaceutical supply chains once treated as rare events are now happening almost every quarter. Speaking with Pharmaceutical Commerce at LogiPharma USA 2026, where he joined the keynote panel "Building Resilient Supply Chains at Scale: Preparing for Disruption, Uncertainty & What's Next," Jayakrishnan traces that pace to the COVID-19 pandemic and the run of shocks that followed. These include global tariff wars, armed conflicts, AI-driven volatility and immigration policies affecting companies with global teams.
Related to this article
来源：Pharmaceutical Commerce · pharmaceuticalcommerce.com